Abstract:Traumatic brain injury (TBI) is a chronic and debilitating disease, associated with a high risk of psychiatric and neurodegenerative diseases. Despite significant advancements in improving outcomes, the lack of effective treatments underscore the urgent need for innovative therapeutic strategies. The brain-gut axis has emerged as a crucial bidirectional pathway connecting the brain and the gastrointestinal (GI) system through an intricate network of neuronal, hormonal, and immunological pathways. Four main pathways are primarily implicated in this crosstalk, including the systemic immune system, autonomic and enteric nervous systems, neuroendocrine system, and microbiome. TBI induces profound changes in the gut, initiating an unrestrained vicious cycle that exacerbates brain injury through the brain-gut axis. Alterations in the gut include mucosal damage associated with the malabsorption of nutrients/electrolytes, disintegration of the intestinal barrier, increased infiltration of systemic immune cells, dysmotility, dysbiosis, enteroendocrine cell (EEC) dysfunction and disruption in the enteric nervous system (ENS) and autonomic nervous system (ANS). Collectively, these changes further contribute to brain neuroinflammation and neurodegeneration via the gut-brain axis. In this review article, we elucidate the roles of various anti-inflammatory pharmacotherapies capable of attenuating the dysregulated inflammatory response along the brain-gut axis in TBI. These agents include hormones such as serotonin, ghrelin, and progesterone, ANS regulators such as beta-blockers, lipid-lowering drugs like statins, and intestinal flora modulators such as probiotics and antibiotics. They attenuate neuroinflammation by targeting distinct inflammatory pathways in both the brain and the gut post-TBI. These therapeutic agents exhibit promising potential in mitigating inflammation along the brain-gut axis and enhancing neurocognitive outcomes for TBI patients.

Heidelberg retina flowmeter parameters at the papilla in healthy subjects.

An Integrated Analysis of Gut Microbiota and the Brain Transcriptome Reveals Host-Gut Microbiota Interactions Following Traumatic Brain Injury.

Gut microbial regulation of innate and adaptive immunity after traumatic brain injury

Complex Feed-Forward and Feedback Mechanisms Underlie the Relationship Between Traumatic Brain Injury and the Gut–Microbiota–Brain Axis

A Retrospective Clinical Analysis of the Serum Bile Acid Alteration Caused by Traumatic Brain Injury

Brain-gut axis dysfunction in the pathogenesis of traumatic brain injury

Gut microbiota and traumatic central nervous system injuries: Insights into pathophysiology and therapeutic approaches

Gut Microbiota and Acute Central Nervous System Injury: A New Target for Therapeutic Intervention

Dual-directional regulation of spinal cord injury and the gut microbiota

The Brain-gut Axis-where are we now and how can we Modulate these Connections?

Traumatic Brain Injury Induces Gastrointestinal Dysfunction and Dysbiosis of Gut Microbiota Accompanied by Alterations of Bile Acid Profile

Dysregulated brain-gut axis in the setting of traumatic brain injury: review of mechanisms and anti-inflammatory pharmacotherapies

Investigating Alterations in Caecum Microbiota After Traumatic Brain Injury in Mice

Bidirectional Brain‐gut‐microbiota Axis in increased intestinal permeability induced by central nervous system injury

A Review of Traumatic Brain Injury and the Gut Microbiome: Insights into Novel Mechanisms of Secondary Brain Injury and Promising Targets for Neuroprotection

Gastrointestinal Microbiome and Neurologic Injury

Extensive bone erosion caused by pseudotumoral aneurysm growth

The Brain–Gut Axis in Traumatic Brain Injury: Implications for Nutrition Support

Spinal cord injury and gut microbiota: A review

Critical knowledge gaps and future priorities regarding the intestinal barrier damage after TBI